News
-
Information regarding compliance with gender balance rules within the Board of Directors
-
Informations relatives au respect des règles de représentation équilibrée au sein du Conseil d’administration
-
Imerys-07-2026-information-share-capital-and-voting-rights-as-of-30-June-2026
-
Imerys-07-2026-communique-capital-droits-de-vote-au-30-juin-2026
-
STEF : Droits de vote au 30-06-2026
-
Four Nines Gold to Showcase Hayden Hill Opportunity to U.S. Investors at OTC Markets Virtual Investor Conference
-
Redwood AI Announces Pricing of $3.5 Million Private Placement
-
Blue Lagoon Surpasses $10 Million In Revenue As Dome Mountain Production Rises To 125 Tonnes Per Day
-
RJK Explorations Ltd. Announces Closing of Private Placement for Gross Proceeds of $310,000
-
LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline
-
ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.06.26
-
Original-Research: Jaguar Health Inc (von First Berlin Equity Research GmbH): Under Review
-
2CRSi SA: Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
-
2CRSi SA: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital as of April 30, 2026
-
EUROPLASMA: FDB Industries : poursuite de l’activité jusqu’au 15 octobre 2026